Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome
|更新时间:2024-01-04
|
Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome
Chinese Journal of Experimental Traditional Medical FormulaeVol. 20, Issue 16, Pages: 142-146(2014)
TANG Han-qing, WANG Jin-hua, ZHAO Shan-min, et al. Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 142-146.
DOI:
TANG Han-qing, WANG Jin-hua, ZHAO Shan-min, et al. Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 142-146. DOI: 10.13422/j.cnki.syfjx.2014160142.
Effects of Xuefu Zhuyu Decoction on Ventricular Remodeling and Cardiac Function in Rabbits with Coronary Heart Disease at Stage of Blood Stasis Syndrome
Objective: To observe the effects of Xuefu Zhuyu decoction on ventricular remodeling and cardiac function in the rabbits with coronary heart disease at the stage of blood stasis syndrome and discuss its therapeutic mechanisms. Method: Sixty healthy rabbits were randomly divided into control group
sham-operation group
model group
and Xuefu Zhuyu decoction low-dose
middle-dose
high-dose groups six groups with ten rabbits in each group. Left coronary artery was implanted constrictor ring to establish the model of coronary heart disease at the stage of blood stasis syndrome. The sham-operation group was just opened the chest but not implanted the constrictor ring. On the basis of the model group from the first day of the twelfth-week after operation
the low-dose
middle-dose
high-dose groups were respectively intragastric administrated(ig) with Xuefu Zhuyu decoction according to 10
20
40 g· kg-1
once a day for continuous twenty-one days while the control group
the model group and the sham-operation group were ig the same volume normal saline
then to record left ventricular end diastolic volume(LVEDV)
left ventricular end systolic vulume (LVESV)
left ventricular end diastolic diameter (LVDd)
left ventricular end systolic diameter (LVDs)
stroke volume (SV)
left ventricular ejection fraction(LVEF)
left ventricular weitht index(LVWI)
right ventricular weitht index(RVWI).To examine the levels of atrial natriuretic peptide(ANP)and angiotensin Ⅱ(AngⅡ)by ELISA and the expression of α-myosin heavy chain(α-MHC)mRNA and β-myosin heavy chain(β-MHC) mRNA by RT-PCR. To test nicotinamide adenine dinucleotide phosphate oxidase(NADPH oxidase) activity by revivification test of cytochrome C. Result: Compared with the control group
in the model group the levels of AngⅡ increased significantly(P<0.01)
the expression of α-MHC mRNA reduced significantly(P<0.01)while the expression of β-MHC mRNA increased significantly(P<0.01)
meantime
LVEDV
LVESV
LVWI and RVWI all increased (P<0.05)
LVDs
SV and LVEF all reduced significantly(P<0.01). Compared with the model group
in the low-dose group the level of ANP reduced(P<0.05). In the middle-dose group NADPH oxidase activity reduced(P<0.05)and the levels of AngⅡ and ANP reduced significantly(P<0.01).In the high-dose group NADPH oxidase activity
the levels of AngⅡ and ANP all reduced significantly(P<0.01). LVEDV
LVESV
LVWI
RVWI
LVDs
SV and LVEF in both the middle-dose group and the high-dose group were improved significantly than those in the low-dose group(P<0.05 or P<0.01). Conclusion: Xuefu Zhuyu decoction could recover the level of AngⅡ in the rabbits with coronary heart disease at the stage of blood stasis syndrome and regulate NADPH oxidase activity
the levels of ANP
α-MHC and β-MHC by AngⅡ mediating
which might be the part of its therapeutic mechanisms.
Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway
Researches on Diagnostic Criteria,Biological Basis,Evidence Based Medicine for Coronary Heart Disease with Blood Stasis Syndrome
IL-6 Gene Promoter Methylation in Patients with Blood Stasis Syndrome and Unstable Angina
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation
Related Author
LIU Yi
YANG Yang
SU Chang
TIAN Peng
WANG Mingyun
ZHONG Ruqian
XIE Xuejiao
YAN Qing
Related Institution
Hunan University of Chinese Medicine
Provincial Key Laboratory of Traditional Chinese Medicine(TCM) Diagnostics, Hunan University of Chinese Medicine
Hunan Traditional Chinese Medical College
Guang'anmen Hospital, China Academy of Chinese Medical Sciences